Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. - Wikidata - awgldk - TriplyDB

Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.

Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.

http://www.wikidata.org/entity/Q46912103

about

PTPN22 R620W Polymorphism is Associated with Myasthenia Gravis Risk: A Systematic Review and Meta-Analysis Small molecule tools for functional interrogation of protein tyrosine phosphatases A Potent and Selective Small-Molecule Inhibitor for the Lymphoid-Specific Tyrosine Phosphatase (LYP), a Target Associated with Autoimmune Diseases Recent advances in the genetics of autoimmune disease Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08 Targeted Deep Sequencing in Multiple-Affected Sibships of European Ancestry Identifies Rare Deleterious Variants in PTPN22 That Confer Risk for Type 1 Diabetes.Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population.Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue.PTPN22 -1123G > C polymorphism is associated with susceptibility to primary immune thrombocytopenia in Chinese population.Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia.The CD45 77C/G allele is not associated with myasthenia gravis - a reassessment of the potential role of CD45 in autoimmunity Coherent somatic mutation in autoimmune disease.Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases.Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?The association of PTPN22 R620W polymorphism is stronger with late-onset AChR-myasthenia gravis in Turkey.Target-specific control of lymphoid-specific protein tyrosine phosphatase (Lyp) activity Protein tyrosine phosphatases as potential therapeutic targets.Genes and Sjögren's syndrome.Altered B cell homeostasis and toll-like receptor 9-driven response in type 1 diabetes carriers of the C1858T PTPN22 allelic variant: implications in the disease pathogenesis PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes.Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population.Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22.Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete.Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing.Complicating autoimmune diseases in myasthenia gravis: a review.The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA.Non-MHC risk alleles in rheumatoid arthritis and in the syntenic chromosome regions of corresponding animal models.Genome-wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A, and Identification of ZBTB10 and Three Distinct HLA Associations.Genetics of autoimmune diseases--disorders of immune homeostasis.STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.Protein tyrosine phosphatases and type 1 diabetes: genetic and functional implications of PTPN2 and PTPN22 Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.Rheumatoid arthritis: a view of the current genetic landscape.General and Specific Genetic Polymorphism of Cytokines-Related Gene in AITD.Whole-genome analysis in Korean patients with autoimmune myasthenia gravis.Thymoma and paraneoplastic myasthenia gravis.Update on the genetic risk factors for rheumatoid arthritis.Genome-Wide Identification of Target Genes for the Key B Cell Transcription Factor Ets1 Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity.Associations between PTPN22 and TLR9 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis.

P2860

Q26796354-46F177A3-DEAE-408F-85EF-7204AB8BE083 Q26852276-BDE664EA-FBAD-4610-BFE1-6F12F3357F6D Q27678355-54800A6D-4AAC-4FE9-94D0-B1B7E27D799D Q28238782-AE979FCF-C285-4259-8CED-54805D55BBB8 Q28943379-2BE6C075-5E08-4273-A9D0-41969B0D8A14 Q30277972-81CBBE05-549A-4D21-857A-5FCEA71F64B4 Q33294087-19FDA4BB-6290-49F6-86FC-03D45FBFEE84 Q33403872-47ECAB00-BD0C-49A0-A36D-E6B971F70120 Q33404016-932BBC30-5D28-4E05-9508-4C0A4FC53360 Q33612241-6FE9DF6E-43D4-4BB7-BDF8-9C019DE7B244 Q33743507-A97F7753-DECF-4926-AEC1-5B2E62B0E905 Q33837769-59B004B0-3CE2-462D-80EA-339B788636AE Q33895460-9A02D207-92AF-4845-A849-526F7F084D84 Q34026657-9FD8C7F9-E5ED-4A02-948B-0A97873FA247 Q34042062-B1821C33-D8C8-4B06-AC31-F479BFCC6CD8 Q34042898-9752C493-B639-4BAC-9A49-DF98C13AE3C2 Q34295063-674A1625-6D88-46EE-A8B8-382DAB8E6C23 Q34363380-7942B46C-B601-4F7A-89DC-3538A73102CA Q34380329-0D013CA8-84E5-4219-870A-6796DC139699 Q34946314-3EBD714E-0453-462D-A0A8-BDF6F4DA4CBE Q35052064-0F0EB381-B23A-44AE-81C5-7A967EFDB09F Q35309080-6EF63CC8-7EE4-4C4F-B494-89D546DED261 Q35854073-253F2537-1A84-468C-8C59-1567E378C639 Q35986928-76A6CBC6-FF0F-4E36-BF15-CBA0E87C97E9 Q36192435-E4CC9B90-D076-4F38-B76C-0F1C8C0DDBE7 Q36456814-57CCCE41-E3D3-44EB-982E-97A9C08E21FB Q36464468-ED9DC4B0-91CD-4C33-950D-22C81BBC7013 Q36568293-8051E125-B59D-4F02-A476-7B5859B5EC0F Q36670483-8BC8C9D1-5ED8-4B01-8D1E-D1A82A33ED38 Q37070948-572B48A1-208E-4830-918D-3747F8930B50 Q37088189-DBB65E18-E4E6-48B9-8370-2D452EA7FA4C Q37107525-E9ED5C27-3E52-4C6A-AFB6-BF5E7201787A Q37315484-553B4A36-2A85-40EC-8190-ED9F22E1E381 Q37590849-7B3656C9-3A4D-46C4-A94E-DB4FF5740D09 Q37708262-D7980F36-720C-4991-A0C3-F1A19F273641 Q37727991-732E7CE2-D668-4706-AE18-5BE1079D20AE Q37729042-9BDA2829-D5F3-46E3-A5B5-B9F6AE7123F9 Q37740649-9A0C66F2-BEAA-47F6-A8EF-95C6EE3905F3 Q38031978-9F08FF0A-40F5-429F-A9A3-AEA4F26D82AC Q38681399-3A3D1B21-96DE-489C-B044-6E72C5590217

P2860

Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.

http://www.wikidata.org/entity/Q46912103

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.

@en

Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.

@nl

type

label

Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.

@en

Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.

@nl

prefLabel

Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.

@en

Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.

@nl

P1433

Q46912103-CA4C4D83-382A-4451-9AB1-A64320D6EFA2

P1476

Q46912103-10F845A3-45C0-4D30-9A39-9C1363730BFD

P2093

Q46912103-3DFCF5A9-C3BF-4A67-846B-EE962DB330C2

Q46912103-615E4FF1-9635-4887-B334-4EFB667AA43D

Q46912103-A5C59B7C-939B-4139-9519-E42FEDEBC378

Q46912103-D633BEEC-2A18-4B14-8BAF-AE324E22CCAA

Q46912103-F9577843-9009-4644-AA47-9249D5525074

Q46912103-FC94D0FE-A74B-4682-AC2A-297AEA5D22E6

P304

Q46912103-5415E118-687D-4FBB-A1F5-C6101696FE0C

P31

Q46912103-9AF07042-8DF6-44E8-B02F-A6D7F9D8B159

P356

Q46912103-43D15BED-30F8-475B-A4C1-BEA9C6A8602E

P433

Q46912103-157BCBB9-7D3A-4A00-8378-DEF431CB07B8

P478

Q46912103-8961F7F6-9036-42DE-BD5D-7D78547CEA07

P50

Q46912103-74261371-C85D-4ACD-8BC0-1C6BA40CD40A

Q46912103-B5DFFE0E-7513-4101-AC58-3D2DA89D8B1B

Q46912103-B98C68AE-480E-4AE5-89F7-960B2970CA48

P577

Q46912103-C0B8404E-0D9C-42C6-A7F5-A321EF527FF4

P698

Q46912103-5BBDE370-BC1A-4A31-9258-632A5C66E8FF

P921

Q46912103-09EBB164-AFB9-4E9B-BB96-A43B6D9861B9

P356

P1433

Annals of Neurology

P1476

Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis

@en

P2093

Bruno Eymard

http://www.w3.org/2001/XMLSchema#string

Claire Capdevielle

http://www.w3.org/2001/XMLSchema#string

Henri-Jean Garchon

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Jais

http://www.w3.org/2001/XMLSchema#string

Philippe Gajdos

http://www.w3.org/2001/XMLSchema#string

Sophie Krumeich

http://www.w3.org/2001/XMLSchema#string

P304

404-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.20751

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Matthieu Giraud

Christine Tranchant

Claire Vandiedonck

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16437561

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis